These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20038301)

  • 1. [Perspective of cervical cancer prevention and control in developing countries and areas].
    Qiao YL
    Chin J Cancer; 2010 Jan; 29(1):1-3. PubMed ID: 20038301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study.
    Shi JF; Canfell K; Lew JB; Zhao FH; Legood R; Ning Y; Simonella L; Ma L; Kang YJ; Zhang YZ; Smith MA; Chen JF; Feng XX; Qiao YL
    BMC Cancer; 2011 Jun; 11():239. PubMed ID: 21668946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
    Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
    Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer: A comprehensive approach towards extermination.
    Bava SV; Thulasidasan AK; Sreekanth CN; Anto RJ
    Ann Med; 2016; 48(3):149-61. PubMed ID: 26911282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cervical cancer screning: from cytology to HPV testing].
    Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening.
    Labani S; Asthana S
    J Epidemiol Community Health; 2016 Jan; 70(1):72-7. PubMed ID: 26248549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing cervical cancer: stakeholder attitudes toward CareHPV-focused screening programs in Roi-et Province, Thailand.
    Trope LA; Chumworathayi B; Blumenthal PD
    Int J Gynecol Cancer; 2009 Nov; 19(8):1432-8. PubMed ID: 20009903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of VIA in cervical cancer screening in low-resource countries.
    Nahar KN; Nessa A; Shamim S; Nasrin B; Hossain F; Begum N
    Mymensingh Med J; 2011 Jul; 20(3):528-35. PubMed ID: 21804524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation.
    Xie Y; Tan X; Shao H; Liu Q; Tou J; Zhang Y; Luo Q; Xiang Q
    BMC Public Health; 2017 Jan; 17(1):118. PubMed ID: 28122530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus infection (HPV) & screening strategies for cervical cancer.
    Sehgal A; Singh V
    Indian J Med Res; 2009 Sep; 130(3):234-40. PubMed ID: 19901432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries.
    Belinson SE; Belinson JL
    Mol Diagn Ther; 2010 Aug; 14(4):215-22. PubMed ID: 20799763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.
    Holt HK; Zhang L; Zhao FH; Hu SY; Zhao XL; Zhang X; Pan QJ; Zhang WH; Smith JS; Qiao YL
    Int J Cancer; 2017 Feb; 140(3):544-554. PubMed ID: 27727464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality.
    Garland SM; Dimech W; Collignon P; ; Cooley L; Nimmo GR; Smith DW; Baird R; Rawlinson W; Costa AM; Higgins G
    J Pathol Clin Res; 2018 Oct; 4(4):207-212. PubMed ID: 30058126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HPV test in cervical screening: a brave new world?
    Desai MS; Cubie HA
    Cytopathology; 2005 Feb; 16(1):3-6. PubMed ID: 15859308
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus (HPV) typing as an adjunct to cervical cancer screening.
    Syrjänen KJ; Syrjänen SM
    Cytopathology; 1999 Feb; 10(1):8-15. PubMed ID: 10068882
    [No Abstract]   [Full Text] [Related]  

  • 20. Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country.
    Cecchini G; Paganini G; D'Amico M; Cannone M; Bertuletti C; Barberis MC
    Pathologica; 2009 Apr; 101(2):76-9. PubMed ID: 19886552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.